Insulin Receptor Substrates Are Essential for the Bioenergetic and Hypertrophic Response of the Heart to Exercise Training

ABSTRACT Insulin and insulin-like growth factor 1 (IGF-1) receptor signaling pathways differentially modulate cardiac growth under resting conditions and following exercise training. These effects are mediated by insulin receptor substrate 1 (IRS1) and IRS2, which also differentially regulate resting cardiac mass. To determine the role of IRS isoforms in mediating the hypertrophic and metabolic adaptations of the heart to exercise training, we subjected mice with cardiomyocyte-specific deletion of either IRS1 (CIRS1 knockout [CIRS1KO] mice) or IRS2 (CIRS2KO mice) to swim training. CIRS1KO hearts were reduced in size under basal conditions, whereas CIRS2KO hearts exhibited hypertrophy. Following exercise swim training in CIRS1KO and CIRS2KO hearts, the hypertrophic response was equivalently attenuated, phosphoinositol 3-kinase (PI3K) activation was blunted, and prohypertrophic signaling intermediates, such as Akt and glycogen synthase kinase 3β (GSK3β), were dephosphorylated potentially on the basis of reduced Janus kinase-mediated inhibition of protein phosphatase 2a (PP2A). Exercise training increased peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) protein content, mitochondrial capacity, fatty acid oxidation, and glycogen synthesis in wild-type (WT) controls but not in IRS1- and IRS2-deficient hearts. PGC-1α protein content remained unchanged in CIRS1KO but decreased in CIRS2KO hearts. These results indicate that although IRS isoforms play divergent roles in the developmental regulation of cardiac size, these isoforms exhibit nonredundant roles in mediating the hypertrophic and metabolic response of the heart to exercise.

[1]  B. Weimer,et al.  Insulin receptor substrate signaling suppresses neonatal autophagy in the heart. , 2013, The Journal of clinical investigation.

[2]  Torsten Doenst,et al.  PGC-1&bgr; Deficiency Accelerates the Transition to Heart Failure in Pressure Overload Hypertrophy , 2011, Circulation research.

[3]  Petra C. Kienesberger,et al.  ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1 , 2011, Nature Medicine.

[4]  E. Abel,et al.  Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. , 2011, Cardiovascular research.

[5]  C. Kahn,et al.  Interaction of myocardial insulin receptor and IGF receptor signaling in exercise-induced cardiac hypertrophy. , 2009, Journal of molecular and cellular cardiology.

[6]  S. Boudina,et al.  Contribution of Impaired Myocardial Insulin Signaling to Mitochondrial Dysfunction and Oxidative Stress in the Heart , 2009, Circulation.

[7]  D. Leroith,et al.  Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. , 2008, Molecular endocrinology.

[8]  R. DePinho,et al.  Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. , 2008, Cell metabolism.

[9]  C. Zechner,et al.  A Role for the Transcriptional Coactivator PGC-1α in Muscle Refueling* , 2007, Journal of Biological Chemistry.

[10]  J. Berger,et al.  Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling. , 2007, Endocrinology.

[11]  M. Birnbaum,et al.  A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. , 2007, Cell metabolism.

[12]  G. Dorn.  The Fuzzy Logic of Physiological Cardiac Hypertrophy , 2007, Hypertension.

[13]  I. Shiojima,et al.  Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. , 2006, Genes & development.

[14]  Anthony J. Muslin,et al.  Akt1 Is Required for Physiological Cardiac Growth , 2006, Circulation.

[15]  R. DePinho,et al.  Class IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy , 2005, Molecular and Cellular Biology.

[16]  J. Olefsky,et al.  Protein Phosphatase 2A Negatively Regulates Insulin's Metabolic Signaling Pathway by Inhibiting Akt (Protein Kinase B) Activity in 3T3-L1 Adipocytes , 2004, Molecular and Cellular Biology.

[17]  Xueying Lin,et al.  Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. , 2004, The Journal of clinical investigation.

[18]  K. M. Popov,et al.  Regular exercise is associated with a protective metabolic phenotype in the rat heart. , 2004, American journal of physiology. Heart and circulatory physiology.

[19]  Anita Y. M. Chan,et al.  Activation of AMP-activated Protein Kinase Inhibits Protein Synthesis Associated with Hypertrophy in the Cardiac Myocyte* , 2004, Journal of Biological Chemistry.

[20]  H. Steen,et al.  Autophosphorylation of JAK2 on Tyrosines 221 and 570 Regulates Its Activity , 2004, Molecular and Cellular Biology.

[21]  P. Kang,et al.  The Insulin-like Growth Factor 1 Receptor Induces Physiological Heart Growth via the Phosphoinositide 3-Kinase(p110α) Pathway* , 2004, Journal of Biological Chemistry.

[22]  P. Kang,et al.  Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  N. Reich,et al.  Determinants for the interaction between Janus kinase 2 and protein phosphatase 2A. , 2003, Archives of biochemistry and biophysics.

[24]  M. Eldar,et al.  Short- and long-term swimming exercise training increases myocardial insulin-like growth factor-I gene expression. , 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[25]  C. Kahn,et al.  Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. , 2002, The Journal of clinical investigation.

[26]  A. Michelucci,et al.  Increased Cardiac Sympathetic Activity and Insulin-Like Growth Factor-I Formation Are Associated With Physiological Hypertrophy in Athletes , 2001, Circulation research.

[27]  H. Vikis,et al.  Regulation of STAT3 by direct binding to the Rac1 GTPase. , 2000, Science.

[28]  P. Kang,et al.  The conserved phosphoinositide 3‐kinase pathway determines heart size in mice , 2000, The EMBO journal.

[29]  B. Lowell,et al.  Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. , 1999, The Journal of clinical investigation.

[30]  S. Gygi,et al.  Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. , 1999, Genes & development.

[31]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[32]  T. Yagi,et al.  Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 , 1994, Nature.

[33]  C. Kahn,et al.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.

[34]  J. Chen,et al.  Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. , 1994, The Journal of biological chemistry.

[35]  J. Chen,et al.  Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. , 1992, Science.

[36]  C. Zechner,et al.  A role for the transcriptional coactivator PGC-1alpha in muscle refueling. , 2007, The Journal of biological chemistry.

[37]  P. Kang,et al.  The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. , 2004, The Journal of biological chemistry.

[38]  J. Sadoshima,et al.  Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. , 2002, Circulation research.

[39]  Kohjiro Ueki,et al.  Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. , 2002, The Journal of clinical investigation.

[40]  S. Boudina,et al.  Open access, freely available online PLoS BIOLOGY PGC-1a Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and , 2022 .